Primary Site >> Colorectal Cancer
Gene >> CCL20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity. PMID: 14500387 |
Ref: Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines. PMID: 16123309 |
Ref: Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. PMID: 16215992 Ref: Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. PMID: 16641550 Ref: Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. PMID: 17075975 |
Ref: CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. PMID: 17621629 Ref: Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. PMID: 17631136 Ref: Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes. PMID: 17667525 |
Ref: TLR4 signaling in cancer cells promotes chemoattraction of immature dendritic cells via autocrine CCL20. PMID: 18083111 |
Ref: The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. PMID: 19480006 Ref: [Regulation of immune suppressive cytokines by TLR4 activation in colon cancer cells]. PMID: 19598032 |
Ref: Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer. PMID: 20211505 |
Ref: The inflammatory microenvironment in colorectal neoplasia. PMID: 21249124 Ref: Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PMID: 21559338 Ref: Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. PMID: 21912453 |
Ref: miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells. PMID: 22099878 Ref: Novel multiplex method to assess insulin, leptin and adiponectin regulation of inflammatory cytokines associated with colon cancer. PMID: 22193626 Ref: Neoadjuvant oral vs. infusional chemoradiotherapy on locally advanced rectal cancer: Prognostic factors. PMID: 24416533 |
Ref: Tumour regression induced by co-administration of MIP-3alpha and CpG in an experimental model of colon carcinoma. PMID: 23672351 Ref: CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies. PMID: 23790181 Ref: miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation. PMID: 23817679 Ref: Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers. PMID: 24349411 |
Ref: A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients. PMID: 24375277 Ref: Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells. PMID: 24559209 Ref: PDCD4 as a predictor of sensitivity to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. PMID: 24568503 Ref: CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition. PMID: 24657657 Ref: [Feasibility study on Xelox (capecitabine plus oxapliplatin) in the volumetric modulated arc therapy (VMAT)-based preoperative chemoradiotherapy for locally advanced rectal cancer]. PMID: 24671807 Ref: The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study. PMID: 24700299 Ref: IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. PMID: 24816405 Ref: Modification of chemokine receptor expression to enhance levels of trafficking receptors on autologous cytokine-induced killer cells derived from patients with colorectal cancer. PMID: 24855035 Ref: CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis. PMID: 24866282 Ref: Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: a systematic review. PMID: 24876730 Ref: Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. PMID: 25000352 |
Ref: Interleukin-17 induces CC chemokine receptor 6 expression and cell migration in colorectal cancer cells. PMID: 25201147 Ref: Intracorporeal versus extracorporeal anastomosis. Results from a multicentre comparative study on 512 right-sided colorectal cancers. PMID: 25414066 Ref: Th22 cell accumulation is associated with colorectal cancer development. PMID: 25892871 Ref: Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis. PMID: 25907800 Ref: Role of endoscopic ultrasonography in the loco-regional staging of patients with rectal cancer. PMID: 26140096 Ref: Preliminary experience with lateral pelvic lymph node dissection in locally advanced rectal cancer. PMID: 26334237 |
Ref: Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview. PMID: 26811629 Ref: Association of pretreatment serum carcinoembryonic antigen levels with chemoradiation-induced downstaging and downsizing of rectal cancer. PMID: 27073681 Ref: Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. PMID: 27100991 Ref: CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition. PMID: 27149649 Ref: Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer. PMID: 27517754 Ref: Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages. PMID: 27622061 Ref: Locally advanced rectal cancer: management challenges. PMID: 27785074 Ref: Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers. PMID: 27845363 |
Ref: Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. PMID: 26719303 Ref: Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-kappaB, and Up-regulating Expression of MicroRNA-21. PMID: 27876571 Ref: Fusobacterium Nucleatum Subspecies Animalis Influences Proinflammatory Cytokine Expression and Monocyte Activation in Human Colorectal Tumors. PMID: 28483840 Ref: Addition of oxaliplatin to neoadjuvant radiochemotherapy in MRI-defined T3, T4 or N+ rectal cancer: a randomized clinical trial. PMID: 28488380 Ref: Psoas hitch ureteral reimplantation after surgery for locally advanced and locally recurrent colorectal cancer: Complications and oncological outcome. PMID: 28732671 Ref: Serum lipidomic study reveals potential early biomarkers for predicting response to chemoradiation therapy in advanced rectal cancer: A pilot study. PMID: 28740922 Ref: Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study. PMID: 28830475 Ref: Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer. PMID: 28974887 |
Ref: Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer : Impact on long-term outcome. Results of the phase II TAKO 05/ABCSG R02 trial. PMID: 29127435 Ref: Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08). PMID: 29241084 Ref: Gut microbiota modulate T cell trafficking into human colorectal cancer. PMID: 29437871 Ref: Preoperative radiotherapy or chemoradiotherapy in rectal cancer - Is survival improved? An update of the "Nordic" LARC study in non-resectable cancers. PMID: 29778486 Ref: Non-operative management of rectal cancer: understanding tumor biology. PMID: 29795066 Ref: The novel long noncoding RNA u50535 promotes colorectal cancer growth and metastasis by regulating CCL20. PMID: 29970882 Ref: Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI. PMID: 30079601 Ref: Radiotherapy for one rectal cancer patient with cirrhosis and moderate to severe thrombocytopenia: a case report. PMID: 30214226 Ref: LncRNA and mRNA signatures associated with neoadjuvant chemoradiotherapy downstaging effects in rectal cancer. PMID: 30320451 |